The shortages stem from manufacturing problems, shipping delays and decisions by some companies to stop producing the medications, according to the Food and Drug Administration.
The decades-old medicines are challenging to make in sterile plants and command a very low price in the United States. But they are considered among the most effective treatments for some cancers without more targeted options, including some breast, lung, and head and neck cancers.
They aren’t profitable enough and are well out of patent… Fucking hell…
Treczoks@lemmy.world 3 days ago
Let me guess: basic ingredients are stuck in Hormuz?
iocase@lemmy.zip 3 days ago
They aren’t profitable enough and are well out of patent… Fucking hell…